Serum alpha-GST activity as an alternative biomarker in olanzapine induced hepatotoxicity under the impact of genetic polymorphism of GSTs
dc.contributor.author | Elkama, Aylin | |
dc.contributor.author | Ak, Mehmet | |
dc.contributor.author | Nemutlu, Emirhan | |
dc.contributor.author | Ilik, Nazlican | |
dc.contributor.author | Karahalil, Bensu | |
dc.date.accessioned | 2024-02-23T14:16:23Z | |
dc.date.available | 2024-02-23T14:16:23Z | |
dc.date.issued | 2017 | |
dc.department | NEÜ | en_US |
dc.description | 53rd Congress of the European-Societies-of-Toxicology (EUROTOX) -- SEP 10-13, 2017 -- Bratislava, SLOVAKIA | en_US |
dc.description.abstract | [Abstract Not Availabe] | en_US |
dc.description.sponsorship | European Soc Toxicol | en_US |
dc.identifier.doi | 10.1016/j.toxlet.2017.07.380 | |
dc.identifier.endpage | S136 | en_US |
dc.identifier.issn | 0378-4274 | |
dc.identifier.issn | 1879-3169 | |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | S136 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.toxlet.2017.07.380 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/12647 | |
dc.identifier.volume | 280 | en_US |
dc.identifier.wos | WOS:000425486700320 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Ireland Ltd | en_US |
dc.relation.ispartof | Toxicology Letters | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [Keyword Not Available] | en_US |
dc.title | Serum alpha-GST activity as an alternative biomarker in olanzapine induced hepatotoxicity under the impact of genetic polymorphism of GSTs | en_US |
dc.type | Conference Object | en_US |